Chronic Diarrhea Associated with High Teriflunomide Blood Concentration

about

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration

Item

http://www.wikidata.org/entity/Q37208447

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration

@en

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration.

@nl

type

Item

label

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration

@en

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration.

@nl

prefLabel

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration

@en

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration.

@nl

P1476

Chronic Diarrhea Associated with High Teriflunomide Blood Concentration

@en

P2093

Anne Julie Frenette

http://www.w3.org/2001/XMLSchema#string

Maxime Doré

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action for leflunomide in rheumatoid arthritis

Clinical pharmacokinetics of leflunomide

Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes

Birth outcomes in women who have taken leflunomide during pregnancy

Experiences with leflunomide in solid organ transplantation.

Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy.

Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis.

Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis.

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.

Hypomagnesemia and proton-pump inhibitors.

P2888

s40744-016-0025-3

P304

179-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S40744-016-0025-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

André Duquette

P577

2016-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291391384

http://www.w3.org/2001/XMLSchema#string

P698

27747512

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

P932

4999575

http://www.w3.org/2001/XMLSchema#string